Dr Michael W Potter, MD | |
100 Dean Dr, Central Point, OR 97502-9706 | |
(541) 944-1490 | |
(541) 664-8291 |
Full Name | Dr Michael W Potter |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 100 Dean Dr, Central Point, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245230143 | NPI | - | NPPES |
XPY187234 | Medicaid | CA | |
079835 | Medicaid | OR |
Mailing Address | Practice Location Address |
---|---|
Dr Michael W Potter, MD 100 Dean Dr, Central Point, OR 97502-9706 Ph: (541) 944-1490 | Dr Michael W Potter, MD 100 Dean Dr, Central Point, OR 97502-9706 Ph: (541) 944-1490 |
News Archive
A team led by Northwestern University chemical biologist Neil Kelleher has developed a new "top-down" method that can separate and identify thousands of protein molecules quickly. Many have been skeptical that such an approach, where each protein is analyzed intact instead of in smaller parts, could be done on such a large scale.
Getting control of COVID-19 will take more than widespread vaccination; it will also require a better understanding of why the disease causes no apparent symptoms in some people but leads to rapid multi-organ failure and death in others, as well as better insight into what treatments work best and for which patients.
In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has signed a Supply Agreement with a premier national and international cell and tissue bank to provide placenta, umbilical cord blood and whole umbilical cord collection services for research purposes.
SuccessEHS has announced the acquisition of MediaDent, a Practice Management, Electronic Dental Record and Dental Imaging solution. MediaDent is the flagship product of Georgia-based MMD Systems Inc., which will operate as a new division of SuccessEHS.
› Verified 6 days ago